(Q73386821)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10648454%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10648454%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

H Lochs

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10648454%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M Mayer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10648454%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

W E Fleig

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10648454%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P B Mortensen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10648454%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P Bauer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10648454%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

D Genser

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10648454%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

W Petritsch

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10648454%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M Raithel

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10648454%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R Hoffmann

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10648454%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

V Gross

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10648454%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M Plauth

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10648454%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M Staun

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10648454%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

L B Nesje

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10648454%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10648454%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10648454%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10648454%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10648454%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

264-273

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10648454%20AND%20SRC:MED&resulttype=core&format=json

Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970208-3

Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970208-3

Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970208-3

Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease. The Italian IBD Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970208-3

A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970208-3

Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970208-3

Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970208-3

The prevention of Crohn's disease after surgery: metronidazole is a small but continuous medical advancement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970208-3

Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970208-3

Oroileal transit of slow release 5-aminosalicylic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970208-3

Delivery and fate of oral mesalamine microgranules within the human small intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970208-3

Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970208-3

Recurrence and reoperation for Crohn's disease: the role of disease location in prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970208-3

Prognosis after surgical treatment for granulomatous enteritis and colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970208-3

The impact of disease pattern, surgical management, and individual surgeons on the risk for relaparotomy for recurrent Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970208-3

Factors affecting recurrence in Crohn's disease. Results of a prospective audit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970208-3

Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970208-3

Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970208-3

Cigarette smoking and inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970208-3

Smoking and sugar intake are separate but interactive risk factors in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970208-3

Effects of smoking on the presentation and clinical course of inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970208-3

10.1016/S0016-5085(00)70208-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10648454%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference